Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tyrosine-protein kinase receptor Tie2 is a receptor tyrosine kinase expressed almost exclusively in endothelial cells. It plays crucial roles in angiogenesis, lymphangiogenesis, and vascular development. Activation occurs through binding to angiopoietin ligands, leading to dimerization and kinase activation. Defects in Tie2 are associated with inherited venous malformations and primary congenital glaucoma. In cancer, Tie2 is expressed in tumor-associated monocytes and contributes to tumor angiogenesis.
Ligand binding induces dimerization and trans-phosphorylation of tyrosine residues, leading to activation of the kinase domain and downstream signaling.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tyrosine-protein kinase receptor Tie2 (TIE2).